Financial Survey: Todos Med (OTCMKTS:TOMDF) vs. Guardian Pharmacy Services (NYSE:GRDN)

Guardian Pharmacy Services (NYSE:GRDN) and Todos Med (OTCMKTS:TOMDF) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, dividends, valuation, institutional ownership and profitability.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Guardian Pharmacy Services and Todos Med, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guardian Pharmacy Services	0	2	7	0	2.78
Todos Med	0	0	0	0	0.00

Guardian Pharmacy Services presently has a consensus price target of $42.83, suggesting a potential upside of 5.26%. Given Guardian Pharmacy Services’ stronger consensus rating and higher probable upside, analysts clearly believe Guardian Pharmacy Services is more favorable than Todos Med.

Risk and Volatility

Guardian Pharmacy Services has a beta of 0.11, meaning that its stock price is 89% less volatile than the S&P 500. Comparatively, Todos Med has a beta of -0.01, meaning that its stock price is 101% less volatile than the S&P 500.

Profitability

This table compares Guardian Pharmacy Services and Todos Med’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Guardian Pharmacy Services	3.64%	30.72%	15.99%
Todos Med	N/A	N/A	N/A

Valuation and Earnings

This table compares Guardian Pharmacy Services and Todos Med”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Guardian Pharmacy Services	$1.45 billion	1.40	$49.22 million	$0.83	49.03
Todos Med	N/A	N/A	N/A	N/A	N/A

Guardian Pharmacy Services has higher revenue and earnings than Todos Med.

Summary

Guardian Pharmacy Services beats Todos Med on 8 of the 8 factors compared between the two stocks.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs. The company was founded in 2003 and is based in Atlanta, Georgia.

About Todos Med

Todos Medical Ltd., a vitro diagnostics company, develops and commercializes blood tests for the detection of cancer and Alzheimer disease in the United States. The company develops Total Biochemical Infrared Analysis, a proprietary cancer-screening technology using peripheral blood spectroscopy analysis for examination into cancer's influence on the immune system; Lymphocyte Proliferation Test, a diagnostic blood test that determines the ability of peripheral blood lymphocytes and monocytes to withstand an exogenous mitogenic stimulation that induces them to enter the cell cycle; and blood tests for the detection of neurodegenerative disorders, such as Alzheimer's disease. Its cancer screening and diagnosis products include TM-B1 and TM-B2 for breast cancer tests; and TMC blood test for the screening and diagnosis of colon cancer. The company also offers Tollovid, a 3CL protease inhibitor dietary supplement to support healthy immune function against circulating coronaviruses; and Tollovir, an antiviral treatment for Covid-19 that is in Phase 2 clinical trial. Todos Medical Ltd. has a collaboration agreement with Integrated Health LLC, as well as has agreements with various companies to develop screening tests for SARS-nCoV-2; and to distribute certain COVID-19 test kits. Todos Medical Ltd. was incorporated in 2010 and is headquartered in Tel Aviv, Israel.